Cardiovascular diseases are a leading cause of morbidity and mortality in most developed countries of the world. Pharmaceuticals, illicit drugs, and toxins can significantly contribute to the overall cardiovascular burden and thus deserve attention. The present article is a systematic overview of drugs that may induce distinct cardiovascular toxicity. The compounds are classified into agents that have significant effects on the heart, blood vessels, or both. The mechanism(s) of toxic action are discussed and treatment modalities are briefly mentioned in relevant cases. Due to the large number of clinically relevant compounds discussed, this article could be of interest to a broad audience including pharmacologists and toxicologists, pharmacists, physicians, and medicinal chemists. Particular emphasis is given to clinically relevant topics including the cardiovascular toxicity of illicit sympathomimetic drugs (e.g., cocaine, amphetamines, cathinones), drugs that prolong the QT interval, antidysrhythmic drugs, digoxin and other cardioactive steroids, beta-blockers, calcium channel blockers, female hormones, nonsteroidal anti-inflammatory, and anticancer compounds encompassing anthracyclines and novel targeted therapy interfering with the HER2 or the vascular endothelial growth factor pathway.

• Klíčová slova
• dysrhythmia, heart failure, hypertension, myocardial infarction, stroke,
• MeSH
• alkaloidy škodlivé účinky   MeSH
• amfetaminy škodlivé účinky   MeSH
• antiarytmika škodlivé účinky   MeSH
• antiflogistika nesteroidní škodlivé účinky   MeSH
• beta blokátory škodlivé účinky   MeSH
• blokátory kalciových kanálů škodlivé účinky   MeSH
• cévní mozková příhoda farmakoterapie   MeSH
• digoxin škodlivé účinky   MeSH
• hormony škodlivé účinky   MeSH
• kardiovaskulární nemoci chemicky indukované   farmakoterapie   MeSH
• kardiovaskulární systém účinky léků   MeSH
• kokain škodlivé účinky   MeSH
• lidé MeSH
• protinádorové látky škodlivé účinky   MeSH
• srdeční frekvence účinky léků   MeSH
• steroidy škodlivé účinky   MeSH
• vaskulární endoteliální růstový faktor A MeSH
• zvířata MeSH
• Check Tag
• lidé MeSH
• mužské pohlaví MeSH
• ženské pohlaví MeSH
• zvířata MeSH
• Publikační typ
• časopisecké články MeSH
• práce podpořená grantem MeSH
• přehledy MeSH
• Názvy látek
• alkaloidy MeSH
• amfetaminy MeSH
• antiarytmika MeSH
• antiflogistika nesteroidní MeSH
• beta blokátory MeSH
• blokátory kalciových kanálů MeSH
• cathinone MeSH Prohlížeč
• digoxin MeSH
• hormony MeSH
• kokain MeSH
• protinádorové látky MeSH
• steroidy MeSH
• vaskulární endoteliální růstový faktor A MeSH

Iron and copper release participates in the myocardial injury under ischemic conditions and hence protection might be achieved by iron chelators. Data on copper chelation are, however, sparse. The effect of the clinically used copper chelator D-penicillamine in the catecholamine model of acute myocardial injury was tested in cardiomyoblast cell line H9c2 and in Wistar Han rats. D-Penicillamine had a protective effect against catecholamine-induced injury both in vitro and in vivo. It protected H9c2 cells against the catecholamine-induced viability loss in a dose-dependent manner. In animals, both intravenous D-penicillamine doses of 11 (low) and 44 mg/kg (high) decreased the mortality caused by s.c. isoprenaline (100 mg/kg) from 36% to 14% and 22%, respectively. However, whereas the low D-penicillamine dose decreased the release of cardiac troponin T (specific marker of myocardial injury), the high dose resulted in an increase. Interestingly, the high dose led to a marked elevation in plasma vitamin C. This might be related to potentiation of oxidative stress, as suggested by additional in vitro experiments with D-penicillamine (iron reduction and the Fenton reaction). In conclusion, D-penicillamine has protective potential against catecholamine-induced cardiotoxicity; however the optimal dose selection seems to be crucial for further application.

• MeSH
• buněčné linie MeSH
• chelátory železa farmakologie   MeSH
• deferoxamin farmakologie   MeSH
• ionty MeSH
• kardiotonika chemie   farmakologie   MeSH
• katecholaminy MeSH
• koncentrace vodíkových iontů MeSH
• myokard patologie   MeSH
• penicilamin chemie   farmakologie   MeSH
• potkani Wistar MeSH
• troponin T metabolismus   MeSH
• viabilita buněk účinky léků   MeSH
• železo metabolismus   MeSH
• zvířata MeSH
• Check Tag
• mužské pohlaví MeSH
• zvířata MeSH
• Publikační typ
• časopisecké články MeSH
• práce podpořená grantem MeSH
• Názvy látek
• chelátory železa MeSH
• deferoxamin MeSH
• ionty MeSH
• kardiotonika MeSH
• katecholaminy MeSH
• penicilamin MeSH
• troponin T MeSH
• železo MeSH